RNS Number : 9566R
Atlantic Lithium Limited
01 November 2023
 

1 November 2023

Change of Registered Office

Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlantic Lithium" or the "Company") advises that, as of today, 1 November 2023, the Company's registered office has changed to:


Level 17, Angel Place,

123 Pitt Street, Sydney, NSW 2000,

Australia


The Company's main telephone numbers remain unchanged.

 

FOR ANY FURTHER INFORMATION, PLEASE CONTACT:

ATLANTIC LITHIUM LIMITED

Neil Herbert (Executive Chairman)

Amanda Harsas (Finance Director and Company Secretary)

Internet with solid fill

www.atlanticlithium.com.au

Envelope with solid fill

IR@atlanticlithium.com.au

Speaker phone with solid fill

Tel: +61 2 8072 0640

 

A logo with text on it Description automatically generated

SP Angel Corporate Finance LLP

Nominated Adviser

Jeff Keating

Charlie Bouverat

Tel: +44 (0)20 3470 0470

A black and white logo Description automatically generated

Yellow Jersey PR Limited

Charles Goodwin

Bessie Elliot
atlantic@yellowjerseypr.com

Tel: +44 (0)20 3004 9512

 

A black and white logo Description automatically generated

Canaccord Genuity Limited

Company Broker

Raj Khatri / James Asensio

Harry Rees

Tel: +44 (0) 20 7523 4500





 

NOTES TO EDITORS:

About Atlantic Lithium

www.atlanticlithium.com.au

Atlantic Lithium is an AIM and ASX-listed lithium company advancing a portfolio of lithium projects in Ghana and Côte d'Ivoire through to production.

The Company's flagship project, the Ewoyaa Project in Ghana, is a significant lithium spodumene pegmatite discovery on track to become Ghana's first lithium-producing mine. The Company signed a funding agreement with Piedmont Lithium Inc. towards the development of the Project. At the Ewoyaa Project, Atlantic Lithium intends to be producing spodumene concentrate via a simple gravity only process flowsheet.

Atlantic Lithium holds 560km2 and 774km2 of tenure across Ghana and Côte d'Ivoire respectively, comprising significantly under-explored, highly prospective licences. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CROZZMGMGMVGFZG